Common Sensing

Common Sensing, founded with a mission to revolutionize healthcare for injectable medicine users, develops and manufactures innovative data-driven hardware and software solutions. The company's core vision is to enhance the quality of life for individuals managing chronic conditions by providing smart, connected devices that offer real-time data insights. Their flagship product, Gocap, is a smart cap for insulin pens that tracks dosage and usage, aiming to improve medication adherence and patient outcomes. Common Sensing primarily targets the healthcare market, focusing on diabetes management.

Notable figures affiliated with Common Sensing include co-founders James White and Richard Whalley, who bring extensive expertise in engineering and healthcare technology. The company has attracted investment from prominent venture capital firms such as Qualcomm Ventures and Waterline Ventures. Key achievements include FDA clearance for their Gocap product and successful partnerships with leading pharmaceutical companies. Overall, Common Sensing has made a significant impact by leveraging technology to address critical needs in chronic disease management, improving patient care and health outcomes.